Abstract A84: Clinical correlates and rationale for PEGylated adenosine deaminase 2 as a novel cancer immunotherapy
Year: 2020
Type: conference-abstract
Source: Cancer Immunology Research
Institution: University of South Carolina
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3012835698
